EGFR and gastric cancer: Her-2/neu, a 185 kDa transmembrane protein, is a member of the human epidermal growth factor receptors (EGFR) family, and its overexpression has been demonstrated in approximately 15–30% of breast and gastric cancers [36,37,38,39,40,41,42].